🔎 Trials Near Me

Home › Alcohol Use Disorder (AUD) › NCT05800899

Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs

Recruiting

Stage II Efficacy Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Admission to a level 1 -trauma center
* Involved in a alcohol-related injury
* Self-identify as Latinx
* 18 or older
* Minimum Blood Alcohol Concentration (BAC) score of .001 and/or at risk drinking

Exclusion Criteria:

* Traumatic brain injury or otherwise debilitating injury as indicated by a Glasgow Coma Scale score of less than 15.
* Cognitive impairment as indicated by a score of 24 or less on the Mini-Mental Status Exam

About the study

This Stage II Randomized Efficacy Trial will compare the effectiveness of a theoretically informed and culturally responsive brief motivational intervention to a non-adapted brief intervention among non-treatment seeking Latinxs admitted for medical treatment of an injury who engage in at risk drinking or were drinking at the time of their injury. The culturally informed brief motivational intervention (CI-BMI) increases autonomous motivation to engage in protective drinking behavior and reduce alcohol problems while addressing barriers to help seeking and facilitating treatment utilization. This project will address the alcohol related health disparities and treatment inequities among Latinx who are more likely to experience alcohol problems yet less likely to receive treatment in order to reduce the negative public health impact of alcohol.

What is being tested

Sponsor: University of Texas, El Paso · Participants: 600 · Started: Jun 30, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT05800899

Locations in the U.S.

TexasUniversity Medical Center of El Paso, El Paso

Conditions

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.